Edward McGill
Finanzdirektor/CFO bei Locki Therapeutics Ltd.
Profil
Edward McGill is currently working as a Financial Controller at 4BIO Ventures Management Ltd.
and Locki Therapeutics Ltd.
He previously worked as a Financial Controller at Disruptive Capital Finance LLP and Enso Ventures Ltd.
Mr. McGill completed his undergraduate degree from Victoria University of Wellington.
Aktive Positionen von Edward McGill
| Unternehmen | Position | Beginn |
|---|---|---|
4BIO Ventures Management Ltd.
 4BIO Ventures Management Ltd. Investment ManagersFinance 4BIO Ventures Management Ltd (4bio Capital Partners) is an independent venture capital firm founded in 2014 by Andrey Kozlov. The firm headquartered in London, United Kingdom. | Comptroller/Controller/Auditor | - |
Locki Therapeutics Ltd.
 Locki Therapeutics Ltd. BiotechnologyHealth Technology Locki Therapeutics Ltd. is a British preclinical stage biotechnology company founded in 2019. The company is based in London, UK. Locki Therapeutics is developing a new class of drugs that enhance the function of beneficial proteins. The company has designed its proprietary encompass™ platform to create enhancement-targeting chimeric (entac™) medicines. These entacs harness the ability of dubs to regulate proteins, expanding the universe of treatable diseases. | Finanzdirektor/CFO | 01.11.2019 |
Ehemalige bekannte Positionen von Edward McGill
| Unternehmen | Position | Ende |
|---|---|---|
Disruptive Capital Finance LLP
 Disruptive Capital Finance LLP Investment ManagersFinance Disruptive Capital Finance LLP (Disruptive Capital) is a private equity firm founded in 2006 by Cédriane Marie de Boucaud Truell, Edmund George Truell and Roger Le Tissiermr. The firm is headquartered in London. | Finanzdirektor/CFO | 31.08.2019 |
Enso Ventures Ltd.
 Enso Ventures Ltd. Investment ManagersFinance Enso Ventures Ltd (Enso Ventures) is an independent venture capital firm founded in 2010 by Nikolay Danilov. The firm is headquartered in London, United Kingdom. | Finanzdirektor/CFO | 01.09.2017 |
Ausbildung von Edward McGill
| Victoria University of Wellington | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Enso Ventures Ltd.
Enso Ventures Ltd. Investment ManagersFinance Enso Ventures Ltd (Enso Ventures) is an independent venture capital firm founded in 2010 by Nikolay Danilov. The firm is headquartered in London, United Kingdom. | Finance |
4BIO Ventures Management Ltd.
4BIO Ventures Management Ltd. Investment ManagersFinance 4BIO Ventures Management Ltd (4bio Capital Partners) is an independent venture capital firm founded in 2014 by Andrey Kozlov. The firm headquartered in London, United Kingdom. | Finance |
Locki Therapeutics Ltd.
Locki Therapeutics Ltd. BiotechnologyHealth Technology Locki Therapeutics Ltd. is a British preclinical stage biotechnology company founded in 2019. The company is based in London, UK. Locki Therapeutics is developing a new class of drugs that enhance the function of beneficial proteins. The company has designed its proprietary encompass™ platform to create enhancement-targeting chimeric (entac™) medicines. These entacs harness the ability of dubs to regulate proteins, expanding the universe of treatable diseases. | Health Technology |
Disruptive Capital Finance LLP
Disruptive Capital Finance LLP Investment ManagersFinance Disruptive Capital Finance LLP (Disruptive Capital) is a private equity firm founded in 2006 by Cédriane Marie de Boucaud Truell, Edmund George Truell and Roger Le Tissiermr. The firm is headquartered in London. | Finance |